Stockreport

TapImmune's (TPIV) CEO Glynn Wilson on Q2 2017 Results - Earnings Call Transcript [Seeking Alpha]

TAPIMMUNE INC COMMON  (TPIV) 
NASDAQ:AMEX Investor Relations: tapimmune.com/investors
PDF TapImmune Inc. (NASDAQ: TPIV ) Q2 2017 Earnings Conference Call August 31, 2017 4:30 PM ET Executives Josh Drumm – Investor Relations Glynn Wilson – Chai [Read more]